Tara E. Jenson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tara E. Jenson has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Amy E. Kalkbrenner
University of Wisconsin–Milwaukee Department of Environmental Health Sciences, Zilber School of Public Health Milwaukee, Wisconsin
2 shared publications Jennifer Weuve
Boston University School of Public Health, Boston, MA, USA
2 shared publications- Marcia Pescador Jimenez
Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
2 shared publications Adam A. Szpiro
University of Washington, Seattle, WA, USA
1 shared publication- Aisha S. Dickerson
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St, Baltimore, MD, 21205, USA
1 shared publication Amanda Gassett
Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, USA
1 shared publication
Latest Publications
- 19 August 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
Confusion in evaluating research quality comes from lack of clarity: the case for explicit research questions
A recent news article suggested that observational studies confuse correlation and causation. Such confusion often arises from unclear research aims rather than inherent limitations in study design. We use this recent public critique of epidemiologic research to illustrate how ambiguity in study questions contributes to misinterpretation of findings. We argue that epidemiologic studies generally fall into 3 distinct categories (descriptive, predictive, and causal) and that each has different goals, assumptions, analytic approaches, and criteria for evaluation. Descriptive studies characterize the distribution of health outcomes, predictive studies aim to identify who will experience those outcomes, and causal studies seek to estimate the effects of interventions or exposures under well-defined counterfactual contrasts. Failure to clearly state which of these aims is being pursued makes it difficult to evaluate methods, assess validity, and interpret results. It also creates opportunities for critiques that may mischaracterize study intent or overstate limitations. We emphasize that observational studies can contribute to causal inference when aligned with explicit causal questions and supported by appropriate assumptions and design choices. We conclude that explicitly stating study aims and estimands would improve scientific communication, facilitate more appropriate critique, and strengthen the contribution of epidemiologic evidence to public health decision-making.
- 19 August 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
Confusion in evaluating research quality comes from lack of clarity: the case for explicit research questions
A recent news article suggested that observational studies confuse correlation and causation. Such confusion often arises from unclear research aims rather than inherent limitations in study design. We use this recent public critique of epidemiologic research to illustrate how ambiguity in study questions contributes to misinterpretation of findings. We argue that epidemiologic studies generally fall into 3 distinct categories (descriptive, predictive, and causal) and that each has different goals, assumptions, analytic approaches, and criteria for evaluation. Descriptive studies characterize the distribution of health outcomes, predictive studies aim to identify who will experience those outcomes, and causal studies seek to estimate the effects of interventions or exposures under well-defined counterfactual contrasts. Failure to clearly state which of these aims is being pursued makes it difficult to evaluate methods, assess validity, and interpret results. It also creates opportunities for critiques that may mischaracterize study intent or overstate limitations. We emphasize that observational studies can contribute to causal inference when aligned with explicit causal questions and supported by appropriate assumptions and design choices. We conclude that explicitly stating study aims and estimands would improve scientific communication, facilitate more appropriate critique, and strengthen the contribution of epidemiologic evidence to public health decision-making.
- Open Access
- 16 June 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (9) , 2355-2363
Depressive symptoms and neuroimaging markers of brain aging in an ethno-racially diverse sample: a Bayesian analysis
Background: Depression has been associated with magnetic resonance imaging (MRI) measures of larger white matter hyperintensity (WMH) volumes and smaller cerebral grey matter volumes (GMV) in predominantly White samples. Recent findings suggest that some race/ethnicity groups may experience more severe health consequences due to depression when it is present compared with experience of depression in White samples. We investigated the association of depressive symptoms with WMH and GMV by race/ethnicity, using a continuous measure of depressive symptoms to more expansively capture participants’ experience of depression versus clinical diagnosis alone. Methods: A diverse sample of older, northern California Kaiser Healthy Aging and Diverse Life Experiences and Study of Healthy Aging in African Americans participants (n = 550) underwent MRI neuroimaging 2017-2022. Baseline depressive symptoms were measured in 2017 using the NIH PROMIS toolbox. We conducted a literature-informed Bayesian analysis, stratified by race/ethnicity, to examine the association between baseline depressive symptoms and post-baseline WMH and GMV. Results: Our sample was 14% Asian, 54% Black, 16% Latino, and 17% White. Overall, we did not observe an association between depressive symptoms and log(WMH) (0.06, 95% Credible Interval [CrI]: -0.09,0.22) or GMV (-0.74, 95% CrI: -1.62,0.16). In stratified analyses, 1 SD higher depressive symptoms were associated with larger log(WMH) volume (0.21, 95%CrI: 0.002,0.42) among Black participants and smaller GMV among Latino participants (-2.92, 95% CrI: -4.31,-1.52). Unexpectedly, depressive symptoms were associated with larger GMV in Asian participants (2.41, 95% CrI: 0.87,3.95). Discussion: More severe depressive symptoms were associated with MRI markers of brain aging among Black and Latino participants.
- 16 June 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (9) , 2355-2363
Open AccessDepressive symptoms and neuroimaging markers of brain aging in an ethno-racially diverse sample: a Bayesian analysis
Background: Depression has been associated with magnetic resonance imaging (MRI) measures of larger white matter hyperintensity (WMH) volumes and smaller cerebral grey matter volumes (GMV) in predominantly White samples. Recent findings suggest that some race/ethnicity groups may experience more severe health consequences due to depression when it is present compared with experience of depression in White samples. We investigated the association of depressive symptoms with WMH and GMV by race/ethnicity, using a continuous measure of depressive symptoms to more expansively capture participants’ experience of depression versus clinical diagnosis alone. Methods: A diverse sample of older, northern California Kaiser Healthy Aging and Diverse Life Experiences and Study of Healthy Aging in African Americans participants (n = 550) underwent MRI neuroimaging 2017-2022. Baseline depressive symptoms were measured in 2017 using the NIH PROMIS toolbox. We conducted a literature-informed Bayesian analysis, stratified by race/ethnicity, to examine the association between baseline depressive symptoms and post-baseline WMH and GMV. Results: Our sample was 14% Asian, 54% Black, 16% Latino, and 17% White. Overall, we did not observe an association between depressive symptoms and log(WMH) (0.06, 95% Credible Interval [CrI]: -0.09,0.22) or GMV (-0.74, 95% CrI: -1.62,0.16). In stratified analyses, 1 SD higher depressive symptoms were associated with larger log(WMH) volume (0.21, 95%CrI: 0.002,0.42) among Black participants and smaller GMV among Latino participants (-2.92, 95% CrI: -4.31,-1.52). Unexpectedly, depressive symptoms were associated with larger GMV in Asian participants (2.41, 95% CrI: 0.87,3.95). Discussion: More severe depressive symptoms were associated with MRI markers of brain aging among Black and Latino participants.
- Open Access
Association of Long-Term Air Pollution Exposure with Dementia-Related Neuropathologies at Autopsy in a Community-Based Cohort
Objective: To evaluate long-term antemortem exposure to four pollutants in relation to Alzheimer’s disease (AD), cerebrovascular, and other dementia-related neuropathologies, measured at autopsy. Design: Retrospective cohort study. Setting: Individual participant data from four Rush Alzheimer’s Disease Center (RADC) longitudinal cohort studies: Memory and Aging Project, Minority Aging Research Study, Rush Clinical Core, and Latino Core. The cohorts enrolled participants residing in Chicago, Illinois (USA), including its metropolitan area and suburbs, and in outlying areas of Illinois. Participants: 909 decedents from the four RADC cohorts who underwent brain autopsy. Setting: RADC cohorts are drawn from northeastern Illinois (IL) and Chicago metropolitan, suburban, and outlying areas of IL. Participants: All participants were aged > 60 years at enrollment. Analyses included 909 decedents with air pollution exposure measures who underwent autopsies prior to 2020 (of 3,579 who enrolled by the end of 2019); all autopsies were from community-based cohorts. Exposures: Exposure to fine particulate matter (PM 2.5 ; particles 2 ), oxides of nitrogen (NO x ; nitrous oxide and NO 2 combined), and ground-level ozone (O 3 ) during the five years preceding death. Exposures were estimated with validated models developed for both the conterminous USA and the Chicago metropolitan area. Main Outcomes and Measures: Twelve dementia-related neuropathologies measured by a neuropathologist at autopsy: Alzheimer’s disease neuropathology (ADNC), β-amyloid density, tau tangle density, cerebral arteriolosclerosis, cerebral atherosclerosis, cerebral amyloid angiopathy, chronic cerebral infarctions (microscopic and gross), hippocampal sclerosis, Lewy bodies and limbic predominant age-related TDP-43 encephalopathy (LATE-NC). Results: Exposure to PM 2.5 and NO 2 , as measured using Chicago-specific models, were both associated with higher tau tangle density [mean difference per 2.5 µg/m 3 PM 2.5 = 0.25 tangles/mm 2 , (95% confidence interval [CI], -0.05 to 0.56); mean difference per 5 ppb NO 2 = 0.10 tangles/mm 2 , (95% CI -0.07 to 0.28)]. PM 2.5 exposure was associated with higher prevalence of arteriolosclerosis [prevalence ratio (PR) per 2.5 µg/m 3 = 1.51 (95% CI, 1.02 to 2.24)]. Both PM 2.5 and NO x exposure were associated with higher prevalence of cerebral atherosclerosis [PR per 2.5 µg/m 3 PM 2.5 = 1.41 (95% CI, 0.93 to 2.13); PR per 5 ppb NO x = 1.10 (95% CI, 0.98 to 1.23)]. None of the exposures was clearly adversely associated with the other neuropathologic outcomes, including β-amyloid density and ADNC. Conclusion and Relevance: Higher exposure to PM 2.5 was associated with cerebral arteriolosclerosis and atherosclerosis at death, consistent with the known vascular toxicity of this pollutant.
Open AccessAssociation of Long-Term Air Pollution Exposure with Dementia-Related Neuropathologies at Autopsy in a Community-Based Cohort
Objective: To evaluate long-term antemortem exposure to four pollutants in relation to Alzheimer’s disease (AD), cerebrovascular, and other dementia-related neuropathologies, measured at autopsy. Design: Retrospective cohort study. Setting: Individual participant data from four Rush Alzheimer’s Disease Center (RADC) longitudinal cohort studies: Memory and Aging Project, Minority Aging Research Study, Rush Clinical Core, and Latino Core. The cohorts enrolled participants residing in Chicago, Illinois (USA), including its metropolitan area and suburbs, and in outlying areas of Illinois. Participants: 909 decedents from the four RADC cohorts who underwent brain autopsy. Setting: RADC cohorts are drawn from northeastern Illinois (IL) and Chicago metropolitan, suburban, and outlying areas of IL. Participants: All participants were aged > 60 years at enrollment. Analyses included 909 decedents with air pollution exposure measures who underwent autopsies prior to 2020 (of 3,579 who enrolled by the end of 2019); all autopsies were from community-based cohorts. Exposures: Exposure to fine particulate matter (PM 2.5 ; particles 2 ), oxides of nitrogen (NO x ; nitrous oxide and NO 2 combined), and ground-level ozone (O 3 ) during the five years preceding death. Exposures were estimated with validated models developed for both the conterminous USA and the Chicago metropolitan area. Main Outcomes and Measures: Twelve dementia-related neuropathologies measured by a neuropathologist at autopsy: Alzheimer’s disease neuropathology (ADNC), β-amyloid density, tau tangle density, cerebral arteriolosclerosis, cerebral atherosclerosis, cerebral amyloid angiopathy, chronic cerebral infarctions (microscopic and gross), hippocampal sclerosis, Lewy bodies and limbic predominant age-related TDP-43 encephalopathy (LATE-NC). Results: Exposure to PM 2.5 and NO 2 , as measured using Chicago-specific models, were both associated with higher tau tangle density [mean difference per 2.5 µg/m 3 PM 2.5 = 0.25 tangles/mm 2 , (95% confidence interval [CI], -0.05 to 0.56); mean difference per 5 ppb NO 2 = 0.10 tangles/mm 2 , (95% CI -0.07 to 0.28)]. PM 2.5 exposure was associated with higher prevalence of arteriolosclerosis [prevalence ratio (PR) per 2.5 µg/m 3 = 1.51 (95% CI, 1.02 to 2.24)]. Both PM 2.5 and NO x exposure were associated with higher prevalence of cerebral atherosclerosis [PR per 2.5 µg/m 3 PM 2.5 = 1.41 (95% CI, 0.93 to 2.13); PR per 5 ppb NO x = 1.10 (95% CI, 0.98 to 1.23)]. None of the exposures was clearly adversely associated with the other neuropathologic outcomes, including β-amyloid density and ADNC. Conclusion and Relevance: Higher exposure to PM 2.5 was associated with cerebral arteriolosclerosis and atherosclerosis at death, consistent with the known vascular toxicity of this pollutant.
- Open Access
- 13 November 2025
- Published by Wolters Kluwer Health in Environmental Epidemiology
- Vol. 9 (6) , e441
Street-view greenspace distribution across racial/ethnic, neighborhood income, and individual education subgroups
Background: The maldistribution of greenspaces across Black, Hispanic, and low-income communities can contribute to health disparities. It is unclear whether the interaction of race/ethnicity and socioeconomic status may explain the maldistribution of greenspace, or whether the maldistribution varies by type of greenspace. Methods: Applying deep learning algorithms to street-view images, we calculated percentages of specific types of residential greenspace (i.e., %Trees, %Grass) for each Multi-Ethnic Study of Atherosclerosis participant (N = 5,858; 2000–2002). We used multilevel analysis of individual heterogeneity and discriminatory accuracy to quantify inequities in greenspace type by intersecting stratum of race/ethnicity (Black, Chinese American, Hispanic, and White), education (high school, some college, and bachelor’s degree), and neighborhood socioeconomic status (NSES; low, moderate, and high). Models adjusted for age, sex, individual income, and study site. Results: The mean %Trees was 19.0 (SD 8.8) and the mean %Grass was 5.1 (4.6). Distribution of %Trees varied across strata, for example, 13.1% (95% confidence interval [CI] = 9.1, 23.8) for Hispanic participants in the lowest education and NSES group versus 20.5% (14.0, 30.4) for Hispanic participants in the highest education and NSES group. Patterns were similar among corresponding strata of Black and Chinese American participants. However, the lowest %Trees among White participants was in the highest NSES and education stratum (20.6, 95% CI = 14.8, 31.5). About 16% of the variability of %Trees and 11% of the variability of %Grass was explained by intersecting stratum of race/ethnicity, education, and NSES. Conclusion: Maldistribution of greenspace types may be explained by combinations of race/ethnicity, education, and NSES subgroups, as opposed to each factor alone.
- 13 November 2025
- Published by Wolters Kluwer Health in Environmental Epidemiology
- Vol. 9 (6) , e441
Open AccessStreet-view greenspace distribution across racial/ethnic, neighborhood income, and individual education subgroups
Background: The maldistribution of greenspaces across Black, Hispanic, and low-income communities can contribute to health disparities. It is unclear whether the interaction of race/ethnicity and socioeconomic status may explain the maldistribution of greenspace, or whether the maldistribution varies by type of greenspace. Methods: Applying deep learning algorithms to street-view images, we calculated percentages of specific types of residential greenspace (i.e., %Trees, %Grass) for each Multi-Ethnic Study of Atherosclerosis participant (N = 5,858; 2000–2002). We used multilevel analysis of individual heterogeneity and discriminatory accuracy to quantify inequities in greenspace type by intersecting stratum of race/ethnicity (Black, Chinese American, Hispanic, and White), education (high school, some college, and bachelor’s degree), and neighborhood socioeconomic status (NSES; low, moderate, and high). Models adjusted for age, sex, individual income, and study site. Results: The mean %Trees was 19.0 (SD 8.8) and the mean %Grass was 5.1 (4.6). Distribution of %Trees varied across strata, for example, 13.1% (95% confidence interval [CI] = 9.1, 23.8) for Hispanic participants in the lowest education and NSES group versus 20.5% (14.0, 30.4) for Hispanic participants in the highest education and NSES group. Patterns were similar among corresponding strata of Black and Chinese American participants. However, the lowest %Trees among White participants was in the highest NSES and education stratum (20.6, 95% CI = 14.8, 31.5). About 16% of the variability of %Trees and 11% of the variability of %Grass was explained by intersecting stratum of race/ethnicity, education, and NSES. Conclusion: Maldistribution of greenspace types may be explained by combinations of race/ethnicity, education, and NSES subgroups, as opposed to each factor alone.
- 20 July 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (2) , 420-431
Racialized experience, biomarkers of lead exposure, and later-life cognition: a mediation analysis
We evaluated the role of the neurotoxicant lead (Pb) in mediating racial disparities in later-life cognition in 1085 non-Hispanic Black and 2839 non-Hispanic white participants in the National Health and Nutrition and Examination Survey (NHANES, 1999-2002, 2011-2014) 60+ years of age. We operationalized Black race as a marker for the experience of racialization and exposure to systemic racism. We estimated patella bone Pb via predictive models using blood Pb and demographics. Concurrent cognition (processing speed, sustained attention, working memory) was measured by the Digit Symbol Substitution Test (DSST) and a global measure combining 4 cognitive tests. To obtain the portion mediated, we used regression coefficients (race on Pb * Pb on cognitive score)/(race on cognitive score), adjusting for age, NHANES cycle, and sample weights. Other confounder adjustment (education, poverty income ratio, smoking) was limited to the mediator-outcome (ie, Pb-cognition) pathway because these factors do not lie upstream of race and so cannot confound associations with race. Lead was estimated to mediate 0.6% of the association between race and global cognition, and 4% of the DSST. Our results suggest that later-life cognitive health disparities may be impacted by avoidable lead exposure driven by environmental injustice, noting that a large proportion of the pathway of systemic racism harming cognition remains. This article is part of a Special Collection on Mental Health.
- 20 July 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (2) , 420-431
Racialized experience, biomarkers of lead exposure, and later-life cognition: a mediation analysis
We evaluated the role of the neurotoxicant lead (Pb) in mediating racial disparities in later-life cognition in 1085 non-Hispanic Black and 2839 non-Hispanic white participants in the National Health and Nutrition and Examination Survey (NHANES, 1999-2002, 2011-2014) 60+ years of age. We operationalized Black race as a marker for the experience of racialization and exposure to systemic racism. We estimated patella bone Pb via predictive models using blood Pb and demographics. Concurrent cognition (processing speed, sustained attention, working memory) was measured by the Digit Symbol Substitution Test (DSST) and a global measure combining 4 cognitive tests. To obtain the portion mediated, we used regression coefficients (race on Pb * Pb on cognitive score)/(race on cognitive score), adjusting for age, NHANES cycle, and sample weights. Other confounder adjustment (education, poverty income ratio, smoking) was limited to the mediator-outcome (ie, Pb-cognition) pathway because these factors do not lie upstream of race and so cannot confound associations with race. Lead was estimated to mediate 0.6% of the association between race and global cognition, and 4% of the DSST. Our results suggest that later-life cognitive health disparities may be impacted by avoidable lead exposure driven by environmental injustice, noting that a large proportion of the pathway of systemic racism harming cognition remains. This article is part of a Special Collection on Mental Health.
- Open Access
Method to Test Etiologic Heterogeneity Among Non-Competing Diagnoses that Accrue Over Time: Application to Discriminating the Impact of Perinatal Exposures on Autism and Attention Deficit Hyperactivity Disorder
Background Testing etiologic heterogeneity – whether a disorder subtype is more or less impacted by a risk factor, is important toward understanding causal pathways and optimizing statistical power. The study of mental health disorders especially benefits from strategic sub-categorization because these disorders are heterogenous and frequently co-occur. Existing methods to quantify etiologic heterogeneity are not appropriate for non-competing events in an open cohort of variable-length follow-up. Thus, we developed a new method. Methods We estimated risks from urban residence, maternal smoking during pregnancy, and parental psychiatric history, with subtypes defined by the presence or absence of a co-diagnosis: autism alone, attention deficit hyperactivity disorder (ADHD) alone, and joint diagnoses of autism+ADHD. To calculate the risk of a single diagnosis (e.g. autism alone), we subtracted the risk for autism+ADHD from the risk for autism overall. We tested the equivalency of average risk ratios over time, using a Wald-type test and bootstrapped standard errors. Results Urban residence was most strongly linked with autism+ADHD and least with ADHD only; maternal smoking was associated with ADHD only but not autism only; and parental psychiatric history exhibited similar associations with all subgroups. Conclusions Our method allowed the calculation of appropriate p values to test strength of association, showing etiologic heterogeneity wherein 2 of these 3 risk factors exhibited different impacts across diagnostic subtypes. The method used all available data, avoided neurodevelopmental outcome misclassification, exhibited robust statistical precision, and is applicable to similar heterogeneous complex conditions using common diagnostic data with variable follow-up.
Open AccessMethod to Test Etiologic Heterogeneity Among Non-Competing Diagnoses that Accrue Over Time: Application to Discriminating the Impact of Perinatal Exposures on Autism and Attention Deficit Hyperactivity Disorder
Background Testing etiologic heterogeneity – whether a disorder subtype is more or less impacted by a risk factor, is important toward understanding causal pathways and optimizing statistical power. The study of mental health disorders especially benefits from strategic sub-categorization because these disorders are heterogenous and frequently co-occur. Existing methods to quantify etiologic heterogeneity are not appropriate for non-competing events in an open cohort of variable-length follow-up. Thus, we developed a new method. Methods We estimated risks from urban residence, maternal smoking during pregnancy, and parental psychiatric history, with subtypes defined by the presence or absence of a co-diagnosis: autism alone, attention deficit hyperactivity disorder (ADHD) alone, and joint diagnoses of autism+ADHD. To calculate the risk of a single diagnosis (e.g. autism alone), we subtracted the risk for autism+ADHD from the risk for autism overall. We tested the equivalency of average risk ratios over time, using a Wald-type test and bootstrapped standard errors. Results Urban residence was most strongly linked with autism+ADHD and least with ADHD only; maternal smoking was associated with ADHD only but not autism only; and parental psychiatric history exhibited similar associations with all subgroups. Conclusions Our method allowed the calculation of appropriate p values to test strength of association, showing etiologic heterogeneity wherein 2 of these 3 risk factors exhibited different impacts across diagnostic subtypes. The method used all available data, avoided neurodevelopmental outcome misclassification, exhibited robust statistical precision, and is applicable to similar heterogeneous complex conditions using common diagnostic data with variable follow-up.
- 4 July 2023
- Published by Springer Nature in Current Epidemiology Reports
- Vol. 10 (3) , 158-167
Outdoor Air Pollution, Environmental Injustice, and Cognitive Decline: a Review
- 4 July 2023
- Published by Springer Nature in Current Epidemiology Reports
- Vol. 10 (3) , 158-167
Outdoor Air Pollution, Environmental Injustice, and Cognitive Decline: a Review
- Open Access
Racialized experience, biomarkers of lead exposure, and later-life cognition: a mediation analysis
We evaluated the role of the neurotoxicant lead (Pb) in mediating racial disparities in later-life cognition in 1,085 non-Hispanic Black and 2,839 non-Hispanic white participants in NHANES (1999-2002, 2011-2014) 60+ years of age. We operationalized Black race as a marker for the experience of racialization and exposure to systemic racism. We estimated patella bone Pb via predictive models using blood Pb and demographics. Concurrent cognition (processing speed, sustained attention, working memory) was measured by the Digit Symbol Substitution Test (DSST) and a global measure combining four cognitive tests. To obtain the portion mediated, we used regression coefficients (race on Pb * Pb on cognitive score)/(race on cognitive score), adjusting for age, NHANES cycle, and sample weights. Other confounder adjustment (education, poverty income ratio, smoking) was limited to the mediator-outcome (i.e., Pb-cognition) pathway because these factors do not lie upstream of race and so cannot confound associations with race. Pb was estimated to mediate 0.6% of the association between race and global cognition, and 4% of the DSST. Our results suggest that later-life cognitive health disparities may be impacted by avoidable lead exposure driven by environmental injustice, noting that a large proportion of the pathway of systemic racism harming cognition remains.
Open AccessRacialized experience, biomarkers of lead exposure, and later-life cognition: a mediation analysis
We evaluated the role of the neurotoxicant lead (Pb) in mediating racial disparities in later-life cognition in 1,085 non-Hispanic Black and 2,839 non-Hispanic white participants in NHANES (1999-2002, 2011-2014) 60+ years of age. We operationalized Black race as a marker for the experience of racialization and exposure to systemic racism. We estimated patella bone Pb via predictive models using blood Pb and demographics. Concurrent cognition (processing speed, sustained attention, working memory) was measured by the Digit Symbol Substitution Test (DSST) and a global measure combining four cognitive tests. To obtain the portion mediated, we used regression coefficients (race on Pb * Pb on cognitive score)/(race on cognitive score), adjusting for age, NHANES cycle, and sample weights. Other confounder adjustment (education, poverty income ratio, smoking) was limited to the mediator-outcome (i.e., Pb-cognition) pathway because these factors do not lie upstream of race and so cannot confound associations with race. Pb was estimated to mediate 0.6% of the association between race and global cognition, and 4% of the DSST. Our results suggest that later-life cognitive health disparities may be impacted by avoidable lead exposure driven by environmental injustice, noting that a large proportion of the pathway of systemic racism harming cognition remains.